Back

Reduced Ferritin heavy chain expression in cardiomyocytes induces ferroptosis-independent cardiac dysfunction in pressure-overloaded mouse hearts

31 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Cardiac hypertrophy, fibrosis, and structural remodelling Heart Failure ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Shigemiki Omiya

National Cerebral & Cardiovascular Center, Suita (Japan)

4 More presentations in this session

Presentation thumbnail
Preclinical study of FAP-specific CAR-T cells in treating myocardial fibrosis
Miss M. Guo (Xuzhou, CN)
Abstract Slides Video
Presentation thumbnail
Fibroblast activation protein expressing valvular interstitial cells define calcific remodelling in aortic stenosis
Mr S. Veizades (Edinburgh, GB)
Abstract Slides Video
Presentation thumbnail
Hypertrophic cardiomyopathy reshapes cardiomyocyte extracellular vesicle output and composition to promote inflammation and extracellular matrix remodelling
Mr W. Seddiq (Oxford, GB)
Abstract Slides Video
Presentation thumbnail
Meyerozyma guilliermondii-derived estriol drives macrophage inflammation via the CD14-TLR4 axis to exacerbate myocardial ischemia-reperfusion injury
Doctor J. Liu (Shanghai, CN)

Access the full session

Session thumbnail
Cardiac hypertrophy, fibrosis, and structural remodelling

The Event

Event poster

ESC Congress 2026

31 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Skeletal muscle-selective deletion of iron regulatory protein 1 and 2 in mice impairs exercise tolerance and cardiac adaptation to increased afterload.
20 May 2023
thumbnail
Congress Presentation
Admission ferritin in cardiogenic shock predicts mortality in the CVICU
21 March 2026
thumbnail
Congress Presentation
Comprehensive proteomics profiling reveals molecular pathways that are differentially regulated in hypertrophic cardiomyopathy and correlate with clinical markers of disease severity
27 August 2021
thumbnail
Congress Presentation
Protosappanin a protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4/FTH1 axis-dependent ferroptosis
30 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources